Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.33 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 3/20 | 0.34 |
| ▸ | MGAM | O43451 | 2/20 | 0.34 |
| ▸ | SI | P14410 | 2/20 | 0.34 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3900431 | 1.00 | KMT2A (0.36) | KMT2ATSHRGAAMGAMSI | |
| SCHEMBL5171967 | 0.99 | KMT2A (0.37) | KMT2ATSHRGAAMGAMSI | |
| SCHEMBL5171973 | 0.99 | KMT2A (0.37) | KMT2ATSHRGAAMGAMSI | |
| Bromide SCHEMBL4865920 | 0.98 | KMT2A (0.36) | KMT2ATSHRGAAMGAMSI | |
| Bromide SCHEMBL4865917 | 0.98 | KMT2A (0.36) | KMT2ATSHRGAAMGAMSI | |
| SCHEMBL4863759 | 0.91 | CA12 (0.38) | KMT2ATSHRGAAMGAMSI | |
| Hydrochloric Acid SCHEMBL4872335 | 0.86 | KMT2A (0.39) | KMT2ATSHRGAAMGAMSI | |
| Hydrochloric Acid SCHEMBL4872332 | 0.86 | KMT2A (0.39) | KMT2ATSHRGAAMGAMSI | |
| Hydrochloric Acid SCHEMBL3912706 | 0.85 | L3MBTL1 (0.40) | KMT2AGAAMGAMSIMGAM2 | |
| Hydrochloric Acid SCHEMBL3912703 | 0.85 | L3MBTL1 (0.40) | KMT2AGAAMGAMSIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1716209-B1 | USE OF COMPOSITION CONTAINING INDOLYL THIAZOLIUM AZO DYES FOR DYING KERATIN FIBERS | WELLA AG (DE) | 2009-03-25 | — | — | EP | claimed |
| EP-1730239-B1 | LIGHTENING COLORANT CONTAINING INDOLYL THIAZOLIUM AZO DYES | WELLA AG (DE) | 2007-05-02 | — | — | EP | claimed |
| US-7431741-B2 | Brightening colorant with indolythiazolium dyes | WELLA AG (DE) | 2008-10-07 | — | — | US | disclosed |
| US-20070180631-A1 | Brightening colorant with indolythiazolium dyes | Wella GmbH (DE) | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070180631-A1 | Brightening colorant with indolythiazolium dyes | KRT18, TUBB1, IK | ACHE 1336/4885CHRM1 2706/4885KMT2A 1177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.